Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trial

Bibliographic Details
Title: Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trial
Authors: Arsene Mekinian, David Saadoun, Eric Vicaut, Sara Thietart, Bertrand Lioger, Patrick Jego, Alexandre Bleibtreu, Nicolas Limal, Jerome Connault, Jacques-Eric Gottenberg, Pauline Lhorte, Jean Pierre Bertola, Juliette Delforge, Nicole Ferreira-Maldent, Antoinette Perlat, Zohra Talib, Matthieu Vautier, Léa Savey, Isabelle Quiere, Patrice Cacoub, Olivier Fain, for the French Takayasu network
Source: Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-7 (2020)
Publisher Information: BMC, 2020.
Publication Year: 2020
Collection: LCC:Diseases of the musculoskeletal system
Subject Terms: Takayasu arteritis, Tocilizumab, Vasculitis treatment, Diseases of the musculoskeletal system, RC925-935
More Details: Abstract Objectives To assess long-term efficacy of tocilizumab in treatment-naive patients with Takayasu arteritis (TAK). Methods Prospective open-labeled trial in naïve patients with TAK who received steroids at the dose of 0.7 mg/kg/day and 7 infusions of 8 mg/kg/month of tocilizumab. The primary endpoint was the number of patients who discontinued steroids after 7 infusions of tocilizumab. Secondary endpoints included disease activity and the number of relapses during 18-month follow-up. Results Thirteen patients with TAK were included, with a median age of 32 years [19–45] and 12 (92%) females. Six (54%) patients met the primary end-point. A significant decrease of disease activity was observed after 6 months of tocilizumab therapy: decrease of median NIH scale (3 [3, 4] at baseline, versus 1 [0–2] after 6 months; p
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1478-6362
Relation: http://link.springer.com/article/10.1186/s13075-020-02311-y; https://doaj.org/toc/1478-6362
DOI: 10.1186/s13075-020-02311-y
Access URL: https://doaj.org/article/749b57ae211149ac81d0ddd3dbfafe91
Accession Number: edsdoj.749b57ae211149ac81d0ddd3dbfafe91
Database: Directory of Open Access Journals
More Details
ISSN:14786362
DOI:10.1186/s13075-020-02311-y
Published in:Arthritis Research & Therapy
Language:English